CVE-2026-66098

MEDIUMCVSS 6.5/10EPSS 0.21%

Last modified

CVE-2026-66098 is a medium-severity vulnerability rated 6.5/10 on the CVSS scale. The Mira hormone monitor device firmware accepts a 0x01 write from any BLE central without authentication, causing the device to reboot into bootloader mode. An attacker could cause a denial-of-service condition or disrupt ovulation tracking and fertility monitoring workflow.. EPSS estimates a 0.21% chance of exploitation in the next 30 days.

Description

The Mira hormone monitor device firmware accepts a 0x01 write from any BLE central without authentication, causing the device to reboot into bootloader mode. An attacker could cause a denial-of-service condition or disrupt ovulation tracking and fertility monitoring workflow.

Metrics

Weakness Enumeration

Affected Software

Source: CNA advisory (CVE.org). NVD analysis pending.

VendorProductVersions
Quanovate Tech Inc. (operating as Mira / Mira Care)Mira Firmware1.7.1.47
Quanovate Tech Inc. (operating as Mira / Mira Care)Mira Android App4.5.15.4

References

Timeline

Published
Last Modified
Status
Awaiting Analysis

Frequently Asked Questions

What is CVE-2026-66098?
The Mira hormone monitor device firmware accepts a 0x01 write from any BLE central without authentication, causing the device to reboot into bootloader mode. An attacker could cause a denial-of-service condition or disrupt ovulation tracking and fertility monitoring workflow.
How severe is CVE-2026-66098?
CVE-2026-66098 has a CVSS score of 6.5/10 (MEDIUM severity). The EPSS model estimates a 0.21% probability of exploitation in the next 30 days.
How do I fix CVE-2026-66098?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

How Strix Helps

Related CVEs from 2026

Are you affected by CVE-2026-66098?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST